Gene expression profiling in DLBCL primary clinical samples

  • Sara Correia Marques (Contributor)
  • Benyamin Ranjbar (Contributor)
  • Maria Bach Laursen (Contributor)
  • Steffen Falgreen (Contributor)
  • Anders Ellern Bilgrau (Contributor)
  • Julie Støve Bødker (Aalborg University) (Contributor)
  • Laura Krogh Jørgensen (Contributor)
  • Maria Nascimento Primo (Contributor)
  • Alexander Schmitz (Contributor)
  • Marianne Schmidt Ettrup (Contributor)
  • Hans Erik Johnsen (Aalborg University) (Contributor)
  • Martin Bøgsted (Contributor)
  • Jacob Giehm Mikkelsen (Contributor)
  • Karen Dybkær (Contributor)



Accession Number: GSE74266

GPL570: [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

Organism: Homo sapiens

Published on 2016-10-05

Gene expression profiling was performed for 28 DLBCL primary clinical samples and assignment of activated B-cell-like(ABC)/germinal center B-cell-like (GCB) DLBCL classes, B-cell-associated gene signature (BAGS), and a probability of response to doxorubicin was performed for each sample.

Overall Design:
28 DLBCL primary clinical samples for which gene expression was determined with Affymetrix GeneChip HG-U133 Plus 2.0 arrays. Gene expression was normalized together with expression from 34 DLBCL primary clinical samples that have been included in GSE56315.

Name: Julie Støve Bødker
Organization: Aalborg University Hospital
Laboratory: Research Laboratory
Deparment: Department of Heamatology
Address: Sdr. Skovvej 15 Aalborg Denmark

Organization: Affymetrix, Inc.
Address: Santa Clara CA 95051 USA
Phone: 888-362-2447
Date made available2016
PublisherGene Expression Omnibus

Cite this